- Data uncertainties mean NICE unable to recommend pemetrexed for the maintenance treatment non-small-cell lung cancer
- Patients, the public and priorities in healthcare
- How do we value innovation?
- NICE Public Board Meeting and NICE Question Time (Cardiff)
- Patients, the public and NICE: Looking forward
- How can we create healthier communities? An asset model
- NICE announces launch of a new database to inform the prioritisation of European cancer research
netvibes
RSS